WallStreetZenWallStreetZen

NASDAQ: ONVO
Organovo Holdings Inc Stock

$1.01-0.04 (-3.81%)
Updated Mar 27, 2024
ONVO Price
$1.01
Fair Value Price
$1.51
Market Cap
$10.14M
52 Week Low
$0.89
52 Week High
$2.31
P/E
-0.47x
P/B
1.64x
P/S
41.81x
PEG
N/A
Dividend Yield
N/A
Revenue
$242.00k
Earnings
-$19.09M
Gross Margin
100%
Operating Margin
-7,885.54%
Profit Margin
-7,886.4%
Debt to Equity
0.44
Operating Cash Flow
-$17M
Beta
1.08
Next Earnings
May 23, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ONVO Overview

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ONVO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ONVO ($1.01) is undervalued by 32.97% relative to our estimate of its Fair Value price of $1.51 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ONVO ($1.01) is significantly undervalued by 32.97% relative to our estimate of its Fair Value price of $1.51 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ONVO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ONVO due diligence checks available for Premium users.

Be the first to know about important ONVO news, forecast changes, insider trades & much more!

ONVO News

Valuation

ONVO fair value

Fair Value of ONVO stock based on Discounted Cash Flow (DCF)
Price
$1.01
Fair Value
$1.51
Undervalued by
32.97%
ONVO ($1.01) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ONVO ($1.01) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ONVO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ONVO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.47x
Industry
14.3x
Market
44.45x

ONVO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.64x
Industry
6.2x
ONVO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ONVO's financial health

Profit margin

Revenue
$5.0k
Net Income
-$3.6M
Profit Margin
-72,080%
ONVO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ONVO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$8.9M
Liabilities
$2.7M
Debt to equity
0.44
ONVO's short-term assets ($6.24M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ONVO's short-term assets ($6.24M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ONVO's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ONVO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.5M
Investing
$27.0k
Financing
$1.2M
ONVO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ONVO vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ONVO$10.14M-3.81%-0.47x1.64x
AEZS$10.10M+4.00%-0.61x0.56x
CVKD$10.25M-1.39%-1.03x1.33x
MBIO$9.77M+0.97%-0.16x79.40x
PRTG$10.68M+1.89%-0.06x0.33x

Organovo Holdings Stock FAQ

What is Organovo Holdings's quote symbol?

(NASDAQ: ONVO) Organovo Holdings trades on the NASDAQ under the ticker symbol ONVO. Organovo Holdings stock quotes can also be displayed as NASDAQ: ONVO.

If you're new to stock investing, here's how to buy Organovo Holdings stock.

What is the 52 week high and low for Organovo Holdings (NASDAQ: ONVO)?

(NASDAQ: ONVO) Organovo Holdings's 52-week high was $2.31, and its 52-week low was $0.89. It is currently -56.28% from its 52-week high and 13.36% from its 52-week low.

How much is Organovo Holdings stock worth today?

(NASDAQ: ONVO) Organovo Holdings currently has 10,040,074 outstanding shares. With Organovo Holdings stock trading at $1.01 per share, the total value of Organovo Holdings stock (market capitalization) is $10.14M.

Organovo Holdings stock was originally listed at a price of $33.00 in Feb 14, 2012. If you had invested in Organovo Holdings stock at $33.00, your return over the last 12 years would have been -96.94%, for an annualized return of -25.21% (not including any dividends or dividend reinvestments).

How much is Organovo Holdings's stock price per share?

(NASDAQ: ONVO) Organovo Holdings stock price per share is $1.01 today (as of Mar 27, 2024).

What is Organovo Holdings's Market Cap?

(NASDAQ: ONVO) Organovo Holdings's market cap is $10.14M, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Organovo Holdings's market cap is calculated by multiplying ONVO's current stock price of $1.01 by ONVO's total outstanding shares of 10,040,074.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.